These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 26992854)

  • 1. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.
    Hong H; Jiang L; Lin Y; He C; Zhu G; Du Q; Wang X; She F; Chen Y
    BMC Cancer; 2016 Mar; 16():240. PubMed ID: 26992854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the "ERK1/2 - AP-1" and "JNK - AP-1" pathways.
    Hong H; He C; Zhu S; Zhang Y; Wang X; She F; Chen Y
    J Exp Clin Cancer Res; 2016 Mar; 35():51. PubMed ID: 27009073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-α promotes the lymphangiogenesis of gallbladder carcinoma through nuclear factor-κB-mediated upregulation of vascular endothelial growth factor-C.
    Du Q; Jiang L; Wang X; Wang M; She F; Chen Y
    Cancer Sci; 2014 Oct; 105(10):1261-71. PubMed ID: 25154789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer.
    Lin W; Jiang L; Chen Y; She F; Han S; Zhu J; Zhou L; Tang N; Wang X; Li X
    Cancer Lett; 2012 Jan; 314(2):127-36. PubMed ID: 22071224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIP1 regulates TNF-α-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-κB-VEGF-C pathway.
    Li CZ; Jiang XJ; Lin B; Hong HJ; Zhu SY; Jiang L; Wang XQ; Tang NH; She FF; Chen YL
    Onco Targets Ther; 2018; 11():2875-2890. PubMed ID: 29844685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cIAP2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the NF-κB pathway.
    Jiang X; Li C; Lin B; Hong H; Jiang L; Zhu S; Wang X; Tang N; Li X; She F; Chen Y
    Cancer Sci; 2017 Jun; 108(6):1144-1156. PubMed ID: 28295868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deguelin--an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model.
    Hu J; Ye H; Fu A; Chen X; Wang Y; Chen X; Ye X; Xiao W; Duan X; Wei Y; Chen L
    Int J Cancer; 2010 Nov; 127(10):2455-66. PubMed ID: 20162567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
    Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
    Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer.
    Ming J; Zhang Q; Qiu X; Wang E
    Eur J Cancer; 2009 Mar; 45(5):866-73. PubMed ID: 19136250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL21/CCR7 up-regulate vascular endothelial growth factor-D expression via ERK pathway in human non-small cell lung cancer cells.
    Sun L; Zhang Q; Li Y; Tang N; Qiu X
    Int J Clin Exp Pathol; 2015; 8(12):15729-38. PubMed ID: 26884842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small molecular agent YL529 inhibits VEGF-D-induced lymphangiogenesis and metastasis in preclinical tumor models in addition to its known antitumor activities.
    Xu Y; Lu W; Yang P; Peng W; Wang C; Li M; Li Y; Li G; Meng N; Lin H; Kan L; Wang S; Yang S; Yu L; Zhao Y
    BMC Cancer; 2015 Jul; 15():525. PubMed ID: 26187637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
    Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
    Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer.
    Sun L; Duan J; Jiang Y; Wang L; Huang N; Lin L; Liao Y; Liao W
    Cancer Lett; 2015 Feb; 357(1):242-253. PubMed ID: 25444928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling.
    Ji H; Cao R; Yang Y; Zhang Y; Iwamoto H; Lim S; Nakamura M; Andersson P; Wang J; Sun Y; Dissing S; He X; Yang X; Cao Y
    Nat Commun; 2014 Sep; 5():4944. PubMed ID: 25229256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
    Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.